Article (Scientific journals)
Efficacy of Erlotinib in patients (PTS) with advanced non-small-cell lung cancer (NSCLC) relative to clinical charesteristics : subset analyses from the trust study
Allan, S.; BOSQUEE, Léon; Franke, A. et al.
2008In American Journal of Clinical Oncology, 26 (20)
Peer Reviewed verified by ORBi
 

Files


Full Text
ASCO_2008_poster%2Dsubgroup_analyses.pdf
Publisher postprint (63.18 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Cardiovascular & respiratory systems
Oncology
Author, co-author :
Allan, S.
BOSQUEE, Léon ;  Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Franke, A.
Pirker, R.
Scagliotti, G.
Language :
English
Title :
Efficacy of Erlotinib in patients (PTS) with advanced non-small-cell lung cancer (NSCLC) relative to clinical charesteristics : subset analyses from the trust study
Publication date :
May 2008
Journal title :
American Journal of Clinical Oncology
ISSN :
0277-3732
eISSN :
1537-453X
Publisher :
Lippincott Williams & Wilkins, Hagerstown, United States - Maryland
Volume :
26
Issue :
20
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 10 March 2011

Statistics


Number of views
34 (1 by ULiège)
Number of downloads
50 (1 by ULiège)

Bibliography


Similar publications



Contact ORBi